EC Gastroenterology and Digestive System

Case Report Volume 10 Issue 4 - 2023

A Rare Case of Infected Isolated Polycystic Liver Disease Presenting Jaundice and Ascites

W Hliwa, I Jbara*, F El Rhaoussi, M Tahiri, F Haddad, A Bellabah and W Badre

Department of Gastroenterology, Ibn Rochd Hospital, Medical University of Casablanca, Morocco

*Corresponding Author: I Jbara, Department of Gastroenterology, Ibn Rochd Hospital, Medical University of Casablanca, Morocco.
Received: April 04, 2023; Published: May 31, 2023



Isolated polycystic liver disease is a rare disease. Patients with isolated polycystic liver disease are usually asymptomatic and the liver cysts are detected incidentally on imaging studies performed for other purposes. Patients rarely develop symptoms, which are most often secondary to cyst enlargement and hepatomegaly. Management of symptomatic PCLD focuses on symptom relief and treatment of complications.

We report the case of a 39-year-old man who presented with ascites and febrile jaundice, whose laboratory tests showed an infectious syndrome, cholestasis and negative hydatid and viral serologies. The CT scan showed a hepatomegaly with multiple cysts of variable size, ascites and normal kidney structure. The diagnosis of isolated polycystic hepatitis was retained. The patient was put on antiobiotherapy with albumin infusion, the patient's clinical and biological condition has improved evolution.

 Keywords: Isolated Polycystic Liver Disease; Jaundice; Ascites; Infectious Hepatic Cyst

  1. Vincent DI Martino. “Maladies kystiques hépatiques non infectieuses”. POST’U (2022).
  2. WR Cnossen and JPH Drenth. “Polycystic liver disease: An overview of pathogenesis, clinical manifestations and management”. Orphanet Journal of Rare Diseases 1 (2014): 69.
  3. Li S Davila., et al. “Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease”. American Journal of Human Genetics 3 (2003): 691-703.
  4. S Davila., et al. “Mutations in SEC63 cause autosomal dominant polycystic liver disease”. Nature Genetics 6 (2004): 575-577.
  5. Boerrigter Masyuk AI., et al. “Autophagy Promotes Hepatic Cystogenesis in Polycystic Liver Disease via Depletion of Cholangiocyte Ciliogenic Proteins”. Hepatology (2022).
  6. Ludovic ROSENFELD., et al. “Les polykystoses hépatiques Principales complications et prise en charge”. Gastroentérologie Clinique et Biologique 26 (2002): 1097-1106.
  7. Qian Q., et al. “Sirolimus reduces polycystic liver volume in ADPKD patients”. Journal of the American Society of Nephrology 3 (2008): 631-638.
  8. Dmitrewski J., et al. “Case report: obstructive jaundice associated with polycystic liver disease”. HPB Surgery 10 (1996): 117-120.
  9. Gelu-Simeon M and Samuel D. “Aspects hépatiques de la polykystose hépato-rénale”. Postu (2014).
  10. Abascal J., et al. “Infection of hepatic cysts in polycystic disease”. World Journal of Surgery 3 (1984): 424-425.
  11. Zhang ZY., et al. “Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management”. World Journal of Hepatology 12 (2020): 72-83.
  12. Vilgrain V. “Lésions kystiques du foie”. Gastroentérologie Clinique et Biologique 25 (2001): B167- B177.
  13. Debenes B., et al. “Kyste solitaire et polykystose hépatique de l’adulte. Cystadénome hépatique”. Editions Techniques - Encycl Med Chir (Paris - France)”. HépatologieA18 (1992): 6.
  14. Danaci M., et al. “The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease”. Nephrology Dialysis Transplantation 13 (1998): 2825-2828.

I Jbara., et al. “A Rare Case of Infected Isolated Polycystic Liver Disease Presenting Jaundice and Ascites”. EC Gastroenterology and Digestive System  10.4 (2023): 37-40.